Mainz Biomed N.V.
MYNZ
$2.27
$0.0050.22%
NASDAQ
| 12/31/2024 | 12/31/2023 | 09/30/2022 | |||
|---|---|---|---|---|---|
| Net Income | -2.51% | 36.70% | -20.62% | ||
| Total Depreciation and Amortization | 27.14% | -16.36% | 806.86% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 899.32% | -94.51% | -51.11% | ||
| Change in Net Operating Assets | -229.56% | -85.48% | 848.54% | ||
| Cash from Operations | 3.92% | 1.21% | -169.21% | ||
| Capital Expenditure | 104.88% | -993.24% | -3,227.87% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 175.00% | -- | -- | ||
| Cash from Investing | 142.36% | -1,668.92% | -133.61% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 73.82% | -844.02% | -298.39% | ||
| Issuance of Common Stock | 47.23% | -- | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 102.67% | 3,265.11% | -101.43% | ||
| Foreign Exchange rate Adjustments | 95.80% | -2,740.93% | -88.42% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 216.87% | 53.76% | -203.90% | ||